Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	PCDH15 DAG1 EYS ADGRE2 CDH2 CDH12 ADGRE3	9.72e-05	749	30	7	GO:0005509
GeneOntologyMolecularFunction	ribosomal small subunit binding	ABCE1 MTIF2	2.93e-04	17	30	2	GO:0043024
GeneOntologyMolecularFunction	D-glucose transmembrane transporter activity	SLC2A1 SLC2A4	6.41e-04	25	30	2	GO:0055056
GeneOntologyMolecularFunction	hexose transmembrane transporter activity	SLC2A1 SLC2A4	6.41e-04	25	30	2	GO:0015149
GeneOntologyMolecularFunction	solute:proton symporter activity	SLC2A13 SLC2A4	6.41e-04	25	30	2	GO:0015295
GeneOntologyMolecularFunction	monosaccharide transmembrane transporter activity	SLC2A1 SLC2A4	7.48e-04	27	30	2	GO:0015145
GeneOntologyMolecularFunction	beta-catenin binding	CDH2 MED12 CDH12	7.63e-04	120	30	3	GO:0008013
GeneOntologyMolecularFunction	sugar transmembrane transporter activity	SLC2A1 SLC2A4	8.64e-04	29	30	2	GO:0051119
GeneOntologyMolecularFunction	carbohydrate transmembrane transporter activity	SLC2A1 SLC2A4	1.81e-03	42	30	2	GO:0015144
GeneOntologyMolecularFunction	proteoglycan binding	HPSE2 TNC	2.66e-03	51	30	2	GO:0043394
GeneOntologyMolecularFunction	SH2 domain binding	DAG1 LCK	2.76e-03	52	30	2	GO:0042169
GeneOntologyBiologicalProcess	response to mechanical stimulus	PCDH15 DAG1 LCK CDH2 TNC SLC2A1	1.59e-06	247	31	6	GO:0009612
GeneOntologyBiologicalProcess	response to abiotic stimulus	PCDH15 GATA6 DAG1 CYP1A1 EYS LCK CDH2 GUCY2F TNC SLC2A1 SLC2A4	2.45e-06	1361	31	11	GO:0009628
GeneOntologyBiologicalProcess	dehydroascorbic acid transport	SLC2A1 SLC2A4	7.82e-05	9	31	2	GO:0070837
GeneOntologyBiologicalProcess	detection of external stimulus	PCDH15 EYS CDH2 GUCY2F	1.26e-04	173	31	4	GO:0009581
GeneOntologyBiologicalProcess	detection of abiotic stimulus	PCDH15 EYS CDH2 GUCY2F	1.32e-04	175	31	4	GO:0009582
GeneOntologyBiologicalProcess	long-chain fatty acid import across plasma membrane	ACSL6 SLC2A1	1.43e-04	12	31	2	GO:0015911
GeneOntologyBiologicalProcess	transport across blood-brain barrier	SLC2A13 SLC2A1 SLC2A4	2.99e-04	87	31	3	GO:0150104
GeneOntologyBiologicalProcess	vascular transport	SLC2A13 SLC2A1 SLC2A4	3.09e-04	88	31	3	GO:0010232
GeneOntologyBiologicalProcess	developmental growth	PCDH15 GATA6 DAG1 IKZF1 EYS TNC MED12	3.32e-04	911	31	7	GO:0048589
GeneOntologyCellularComponent	photoreceptor outer segment	PCDH15 EYS SHANK2 GUCY2F	2.12e-05	111	31	4	GO:0001750
GeneOntologyCellularComponent	photoreceptor cell cilium	PCDH15 EYS SHANK2 GUCY2F	5.12e-05	139	31	4	GO:0097733
GeneOntologyCellularComponent	9+0 non-motile cilium	PCDH15 EYS SHANK2 GUCY2F	7.44e-05	153	31	4	GO:0097731
GeneOntologyCellularComponent	sarcolemma	DAG1 CDH2 SLC2A1 SLC2A4	1.72e-04	190	31	4	GO:0042383
GeneOntologyCellularComponent	membrane raft	DAG1 LCK CDH2 SLC2A1 SLC2A4	1.78e-04	362	31	5	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	DAG1 LCK CDH2 SLC2A1 SLC2A4	1.82e-04	364	31	5	GO:0098857
GeneOntologyCellularComponent	non-motile cilium	PCDH15 EYS SHANK2 GUCY2F	1.93e-04	196	31	4	GO:0097730
GeneOntologyCellularComponent	anchoring junction	DAG1 LCK CDH2 RPL3 TNC SLC2A1 CDH12	4.65e-04	976	31	7	GO:0070161
GeneOntologyCellularComponent	cytosolic ribosome	RPL3 ABCE1 RPL3L	8.11e-04	124	31	3	GO:0022626
GeneOntologyCellularComponent	catenin complex	CDH2 CDH12	1.03e-03	32	31	2	GO:0016342
GeneOntologyCellularComponent	plasma membrane raft	DAG1 CDH2 SLC2A1	1.33e-03	147	31	3	GO:0044853
GeneOntologyCellularComponent	cell-cell junction	DAG1 LCK CDH2 SLC2A1 CDH12	1.64e-03	591	31	5	GO:0005911
GeneOntologyCellularComponent	extracellular matrix	DAG1 HPSE2 EYS CDH2 TNC	2.59e-03	656	31	5	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	DAG1 HPSE2 EYS CDH2 TNC	2.62e-03	658	31	5	GO:0030312
GeneOntologyCellularComponent	cytosolic large ribosomal subunit	RPL3 RPL3L	3.45e-03	59	31	2	GO:0022625
GeneOntologyCellularComponent	focal adhesion	DAG1 CDH2 RPL3 TNC	3.61e-03	431	31	4	GO:0005925
GeneOntologyCellularComponent	adherens junction	DAG1 CDH2 CDH12	3.75e-03	212	31	3	GO:0005912
GeneOntologyCellularComponent	cell-substrate junction	DAG1 CDH2 RPL3 TNC	3.98e-03	443	31	4	GO:0030055
Domain	Sugar/inositol_transpt	SLC2A13 SLC2A1 SLC2A4	1.49e-06	14	31	3	IPR003663
Domain	SUGAR_TRANSPORT_2	SLC2A13 SLC2A1 SLC2A4	2.77e-06	17	31	3	PS00217
Domain	Ribosomal_L3	RPL3 RPL3L	7.99e-06	3	31	2	PF00297
Domain	Ribosomal_L3	RPL3 RPL3L	7.99e-06	3	31	2	IPR000597
Domain	RIBOSOMAL_L3	RPL3 RPL3L	7.99e-06	3	31	2	PS00474
Domain	Ribosomal_L3_CS	RPL3 RPL3L	7.99e-06	3	31	2	IPR019926
Domain	SUGAR_TRANSPORT_1	SLC2A13 SLC2A1 SLC2A4	8.18e-06	24	31	3	PS00216
Domain	Transl_B-barrel	RPL3 RPL3L MTIF2	1.18e-05	27	31	3	IPR009000
Domain	Sugar_transporter_CS	SLC2A13 SLC2A1 SLC2A4	1.99e-05	32	31	3	IPR005829
Domain	Sugar_tr	SLC2A13 SLC2A1 SLC2A4	2.85e-05	36	31	3	PF00083
Domain	MFS_sugar_transport-like	SLC2A13 SLC2A1 SLC2A4	2.85e-05	36	31	3	IPR005828
Domain	MFS	SLC49A3 SLC2A13 SLC2A1 SLC2A4	2.95e-05	108	31	4	PS50850
Domain	Cadherin-like	PCDH15 DAG1 CDH2 CDH12	3.90e-05	116	31	4	IPR015919
Domain	MFS_dom	SLC49A3 SLC2A13 SLC2A1 SLC2A4	6.86e-05	134	31	4	IPR020846
Domain	Growth_fac_rcpt_	EYS ADGRE2 TNC ADGRE3	1.24e-04	156	31	4	IPR009030
Domain	EGF_Ca-bd_CS	EYS ADGRE2 ADGRE3	5.49e-04	97	31	3	IPR018097
Domain	EGF_CA	EYS ADGRE2 ADGRE3	5.83e-04	99	31	3	PS01187
Domain	EGF_3	EYS ADGRE2 TNC ADGRE3	5.89e-04	235	31	4	PS50026
Domain	EGF	EYS ADGRE2 TNC ADGRE3	5.89e-04	235	31	4	SM00181
Domain	ASX_HYDROXYL	EYS ADGRE2 ADGRE3	6.00e-04	100	31	3	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	EYS ADGRE2 ADGRE3	7.11e-04	106	31	3	IPR000152
Domain	EGF-like_dom	EYS ADGRE2 TNC ADGRE3	7.31e-04	249	31	4	IPR000742
Domain	Cadherin_CS	PCDH15 CDH2 CDH12	7.72e-04	109	31	3	IPR020894
Domain	Cadherin_C	CDH2 CDH12	7.81e-04	25	31	2	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH2 CDH12	7.81e-04	25	31	2	IPR000233
Domain	Cadherin	PCDH15 CDH2 CDH12	8.57e-04	113	31	3	PF00028
Domain	CADHERIN_1	PCDH15 CDH2 CDH12	8.57e-04	113	31	3	PS00232
Domain	CADHERIN_2	PCDH15 CDH2 CDH12	8.79e-04	114	31	3	PS50268
Domain	-	PCDH15 CDH2 CDH12	8.79e-04	114	31	3	2.60.40.60
Domain	CA	PCDH15 CDH2 CDH12	9.01e-04	115	31	3	SM00112
Domain	Cadherin	PCDH15 CDH2 CDH12	9.71e-04	118	31	3	IPR002126
Domain	Catenin_binding_dom	CDH2 CDH12	1.05e-03	29	31	2	IPR027397
Domain	-	CDH2 CDH12	1.05e-03	29	31	2	4.10.900.10
Domain	EGF_CA	EYS ADGRE2 ADGRE3	1.07e-03	122	31	3	SM00179
Domain	EGF-like_Ca-bd_dom	EYS ADGRE2 ADGRE3	1.12e-03	124	31	3	IPR001881
Domain	GPS	ADGRE2 ADGRE3	1.45e-03	34	31	2	SM00303
Domain	GPCR_2_secretin-like_CS	ADGRE2 ADGRE3	1.45e-03	34	31	2	IPR017983
Domain	GPS	ADGRE2 ADGRE3	1.53e-03	35	31	2	PF01825
Domain	GPS	ADGRE2 ADGRE3	1.62e-03	36	31	2	PS50221
Domain	GPS	ADGRE2 ADGRE3	1.71e-03	37	31	2	IPR000203
Domain	G_PROTEIN_RECEP_F2_2	ADGRE2 ADGRE3	3.11e-03	50	31	2	PS00650
Domain	7tm_2	ADGRE2 ADGRE3	3.11e-03	50	31	2	PF00002
Domain	GPCR_2-like	ADGRE2 ADGRE3	4.44e-03	60	31	2	IPR017981
Domain	GPCR_2_secretin-like	ADGRE2 ADGRE3	4.44e-03	60	31	2	IPR000832
Domain	G_PROTEIN_RECEP_F2_4	ADGRE2 ADGRE3	4.59e-03	61	31	2	PS50261
Domain	EGF_1	EYS ADGRE2 TNC	8.53e-03	255	31	3	PS00022
Domain	EGF_CA	ADGRE2 ADGRE3	8.94e-03	86	31	2	PF07645
Domain	EGF-like_CS	EYS ADGRE2 TNC	9.08e-03	261	31	3	IPR013032
Domain	EGF_2	EYS ADGRE2 TNC	9.47e-03	265	31	3	PS01186
Pubmed	Glucose transporter gene expression in early mouse embryos.	LCK SLC2A1 SLC2A4	5.18e-07	18	31	3	1765007
Pubmed	GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts.	GATA6 TNC	7.69e-07	2	31	2	18177748
Pubmed	Insulin-sensitive regulation of glucose transport and GLUT4 translocation in skeletal muscle of GLUT1 transgenic mice.	SLC2A1 SLC2A4	7.69e-07	2	31	2	9854024
Pubmed	Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells.	SLC2A1 SLC2A4	7.69e-07	2	31	2	24932809
Pubmed	A novel ribosomal protein L3-like gene (RPL3L) maps to the autosomal dominant polycystic kidney disease gene region.	RPL3 RPL3L	7.69e-07	2	31	2	8921388
Pubmed	RPL3L-containing ribosomes determine translation elongation dynamics required for cardiac function.	RPL3 RPL3L	7.69e-07	2	31	2	37080962
Pubmed	Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.	SLC2A1 SLC2A4	7.69e-07	2	31	2	19648108
Pubmed	The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis.	SLC2A1 SLC2A4	7.69e-07	2	31	2	18796630
Pubmed	Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues.	SLC2A1 SLC2A4	7.69e-07	2	31	2	12712244
Pubmed	Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue.	SLC2A1 SLC2A4	7.69e-07	2	31	2	19955252
Pubmed	Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice.	SLC2A1 SLC2A4	7.69e-07	2	31	2	8798515
Pubmed	3T3-L1 adipocyte glucose transporter (HepG2 class): sequence and regulation of protein and mRNA expression by insulin, differentiation, and glucose starvation.	SLC2A1 SLC2A4	7.69e-07	2	31	2	2190533
Pubmed	Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake.	SLC2A1 SLC2A4	7.69e-07	2	31	2	28589878
Pubmed	Somatic cell-like features of cloned mouse embryos prepared with cultured myoblast nuclei.	SLC2A1 SLC2A4	7.69e-07	2	31	2	12606377
Pubmed	Expression of Muscle-Specific Ribosomal Protein L3-Like Impairs Myotube Growth.	RPL3 RPL3L	7.69e-07	2	31	2	26684695
Pubmed	A potential role for glucose transporters in the evolution of human brain size.	SLC2A1 SLC2A4	7.69e-07	2	31	2	21986508
Pubmed	Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice.	SLC2A1 SLC2A4	7.69e-07	2	31	2	7977725
Pubmed	Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes.	SLC2A1 SLC2A4	7.69e-07	2	31	2	2654938
Pubmed	Dynamic interplay between RPL3- and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heart.	RPL3 RPL3L	7.69e-07	2	31	2	36882085
Pubmed	Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human endometrium: a physiological and cyclical condition of tissue insulin resistance.	SLC2A1 SLC2A4	2.31e-06	3	31	2	22971162
Pubmed	Tracking and characterization of partial and full epithelial-mesenchymal transition cells in a mouse model of metastatic breast cancer.	CDH2 TNC	2.31e-06	3	31	2	35707685
Pubmed	GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle.	SLC2A1 SLC2A4	2.31e-06	3	31	2	22681646
Pubmed	Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta.	SLC2A1 SLC2A4	2.31e-06	3	31	2	27981520
Pubmed	Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes.	SLC2A1 SLC2A4	2.31e-06	3	31	2	12064911
Pubmed	Triiodothyronine acutely stimulates glucose transport into L6 muscle cells without increasing surface GLUT4, GLUT1, or GLUT3.	SLC2A1 SLC2A4	2.31e-06	3	31	2	22663547
Pubmed	Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis.	SLC2A1 SLC2A4	2.31e-06	3	31	2	17611657
Pubmed	Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes.	SLC2A1 SLC2A4	2.31e-06	3	31	2	17389706
Pubmed	Analysis of correlations between the placental expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 and selected maternal and fetal parameters in pregnancies complicated by diabetes mellitus.	SLC2A1 SLC2A4	2.31e-06	3	31	2	28969476
Pubmed	The genetic basis for specific anosmia to isovaleric acid in the mouse.	LCK SLC2A1	2.31e-06	3	31	2	8521470
Pubmed	The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1.	SLC2A1 SLC2A4	4.61e-06	4	31	2	11842083
Pubmed	Structural analysis of the GLUT1 facilitative glucose transporter (review).	SLC2A1 SLC2A4	4.61e-06	4	31	2	11681785
Pubmed	Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors.	SLC2A1 SLC2A4	4.61e-06	4	31	2	8457197
Pubmed	Placental glucose transfer and fetal growth.	SLC2A1 SLC2A4	4.61e-06	4	31	2	12583599
Pubmed	In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle.	SLC2A1 SLC2A4	4.61e-06	4	31	2	10455018
Pubmed	Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues.	SLC2A1 SLC2A4	4.61e-06	4	31	2	2656669
Pubmed	The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells.	SLC2A1 SLC2A4	4.61e-06	4	31	2	10655495
Pubmed	Age-associated alterations in cardiac and skeletal muscle glucose transporters, insulin and IGF-1 receptors, and PI3-kinase protein contents in the C57BL/6 mouse.	SLC2A1 SLC2A4	4.61e-06	4	31	2	10100151
Pubmed	α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake.	SLC2A1 SLC2A4	4.61e-06	4	31	2	26832303
Pubmed	Prenatal Exposure to Sodium Arsenite Alters Placental Glucose 1, 3, and 4 Transporters in Balb/c Mice.	SLC2A1 SLC2A4	4.61e-06	4	31	2	26339590
Pubmed	Functional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking.	SLC2A1 SLC2A4	4.61e-06	4	31	2	14562105
Pubmed	Extra-nuclear telomerase reverse transcriptase (TERT) regulates glucose transport in skeletal muscle cells.	SLC2A1 SLC2A4	4.61e-06	4	31	2	24970747
Pubmed	Genetic map of rat chromosome 5 including the fatty (fa) locus.	LCK SLC2A1	4.61e-06	4	31	2	7719022
Pubmed	Immunohistochemical localization and quantification of glucose transporters in the mouse brain.	SLC2A1 SLC2A4	4.61e-06	4	31	2	11955709
Pubmed	Leptin at gender-specific concentrations does not affect glucose transport, expression of glucose transporters and leptin receptors in human lymphocytes.	SLC2A1 SLC2A4	7.68e-06	5	31	2	25306890
Pubmed	Distinct contributions of partial and full EMT to breast cancer malignancy.	CDH2 TNC	7.68e-06	5	31	2	34847378
Pubmed	Developmental expression and cellular localization of glucose transporter molecules during mouse preimplantation development.	SLC2A1 SLC2A4	7.68e-06	5	31	2	1638987
Pubmed	The glucose transporter family: structure, function and tissue-specific expression.	SLC2A1 SLC2A4	7.68e-06	5	31	2	8240230
Pubmed	Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading.	SLC2A1 SLC2A4	7.68e-06	5	31	2	12145475
Pubmed	Prenatal expression of the GLUT4 glucose transporter in the mouse.	SLC2A1 SLC2A4	7.68e-06	5	31	2	10965149
Pubmed	Differential screening of a PCR-generated mouse embryo cDNA library: glucose transporters are differentially expressed in early postimplantation mouse embryos.	SLC2A1 SLC2A4	7.68e-06	5	31	2	1289053
Pubmed	Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene.	CDH2 CDH12	1.15e-05	6	31	2	7731968
Pubmed	Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis.	SLC2A1 SLC2A4	1.15e-05	6	31	2	1618860
Pubmed	Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT).	SLC2A1 SLC2A4	1.15e-05	6	31	2	26572137
Pubmed	The EGF-TM7 family: a postgenomic view.	ADGRE2 ADGRE3	1.15e-05	6	31	2	14647991
Pubmed	Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.	LCK SLC2A1	1.15e-05	6	31	2	8104199
Pubmed	Synip: a novel insulin-regulated syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes.	SLC2A1 SLC2A4	1.15e-05	6	31	2	10394363
Pubmed	Glucose uptake mediated by glucose transporter 1 is essential for early tooth morphogenesis and size determination of murine molars.	SLC2A1 SLC2A4	1.15e-05	6	31	2	22226978
Pubmed	PCR-analyzed microsatellites of the mouse genome--additional polymorphisms among ten inbred mouse strains.	CYP1A1 SLC2A4	1.61e-05	7	31	2	1611214
Pubmed	The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.	SLC2A1 SLC2A4	1.61e-05	7	31	2	18511518
Pubmed	Molecular mapping of the mouse db mutation.	LCK SLC2A1	1.61e-05	7	31	2	1978328
Pubmed	Essential role of glucose transporter GLUT3 for post-implantation embryonic development.	CDH2 SLC2A1	1.61e-05	7	31	2	18948350
Pubmed	Assignment of 12 loci to rat chromosome 5: evidence that this chromosome is homologous to mouse chromosome 4 and to human chromosomes 9 and 1 (1p arm).	LCK SLC2A1	2.15e-05	8	31	2	2341157
Pubmed	Linkage analysis of 84 microsatellite markers in intra- and interspecific backcrosses.	LCK SLC2A4	2.15e-05	8	31	2	1643308
Pubmed	Microdissection and microcloning of mid-chromosome 4: genetic mapping of 41 microdissection clones.	LCK SLC2A1	2.15e-05	8	31	2	8098006
Pubmed	Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.	SLC2A1 SLC2A4	2.76e-05	9	31	2	19554504
Pubmed	Transcriptional regulation of muscle-specific genes during myoblast differentiation.	SLC2A1 SLC2A4	2.76e-05	9	31	2	9600108
Pubmed	Identification of genes associated with non-small-cell lung cancer promotion and progression.	SLC2A13 CDH12	2.76e-05	9	31	2	19473719
Pubmed	Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries.	SLC2A1 SLC2A4	3.44e-05	10	31	2	12533615
Pubmed	Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue.	CDH2 CDH12	3.44e-05	10	31	2	2059658
Pubmed	Mapping of PCR-based markers for mouse chromosome 4 on a backcross penetrant for the misty (m) mutation.	LCK SLC2A1	3.44e-05	10	31	2	7949731
Pubmed	Genetic mapping of meander tail, a mouse mutation affecting cerebellar development.	LCK SLC2A1	3.44e-05	10	31	2	2037292
Pubmed	Pax6-dependent regulation of adhesive patterning, R-cadherin expression and boundary formation in developing forebrain.	CDH2 TNC	4.21e-05	11	31	2	9367432
Pubmed	Neural Deletion of Glucose Transporter Isoform 3 Creates Distinct Postnatal and Adult Neurobehavioral Phenotypes.	SLC2A1 SLC2A4	4.21e-05	11	31	2	30232223
Pubmed	Regulation of cochlear convergent extension by the vertebrate planar cell polarity pathway is dependent on p120-catenin.	PCDH15 CDH2	5.05e-05	12	31	2	22318628
Pubmed	Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.	CDH2 CDH12	5.96e-05	13	31	2	9615235
Pubmed	Foxp1 suppresses cortical angiogenesis and attenuates HIF-1alpha signaling to promote neural progenitor cell maintenance.	SLC2A1 SLC2A4	6.95e-05	14	31	2	38600346
Pubmed	Transcription profile during maternal to zygotic transition in the mouse embryo.	RPL3 ABCE1	6.95e-05	14	31	2	16930510
Pubmed	Trophectoderm mechanics direct epiblast shape upon embryo implantation.	GATA6 CDH2	6.95e-05	14	31	2	33472064
Pubmed	Differential Spatiotemporal Expression of Type I and Type II Cadherins Associated With the Segmentation of the Central Nervous System and Formation of Brain Nuclei in the Developing Mouse.	CDH2 CDH12	8.02e-05	15	31	2	33833667
Pubmed	No evidence of involvement of E-cadherin in cell fate specification or the segregation of Epi and PrE in mouse blastocysts.	GATA6 CDH2	8.02e-05	15	31	2	30735538
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	DAG1 CDH2 TNC	8.93e-05	97	31	3	27559042
Pubmed	The transcription factor Rreb1 regulates epithelial architecture, invasiveness, and vasculogenesis in early mouse embryos.	GATA6 CDH2	9.16e-05	16	31	2	33929320
Pubmed	Genome-wide analysis of sex-specific differences in the mother-child PELAGIE cohort exposed to organophosphate metabolites.	GATA6 CDH2	1.04e-04	17	31	2	37198424
Pubmed	Mutations in linker-2 of KLF1 impair expression of membrane transporters and cytoskeletal proteins causing hemolysis.	SLC2A1 SLC2A4	1.04e-04	17	31	2	39147774
Pubmed	JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse.	DAG1 SHANK2	1.04e-04	17	31	2	26627310
Pubmed	Blood-Brain Barrier: From Physiology to Disease and Back.	SLC2A13 SLC2A1 SLC2A4	1.13e-04	105	31	3	30280653
Pubmed	Mfsd2b and Spns2 are essential for maintenance of blood vessels during development and in anaphylactic shock.	CDH2 SLC2A1	1.17e-04	18	31	2	35977478
Pubmed	p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation.	SLC2A1 SLC2A4	1.17e-04	18	31	2	15800058
Pubmed	Intrauterine Pressures Adjusted by Reichert's Membrane Are Crucial for Early Mouse Morphogenesis.	GATA6 DAG1	1.17e-04	18	31	2	32433954
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	DAG1 CDH2 RPL3 TNC	1.17e-04	285	31	4	21423176
Pubmed	Prethymic T-cell development defined by the expression of paired immunoglobulin-like receptors.	IKZF1 LCK	1.30e-04	19	31	2	16292344
Pubmed	E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.	CDH2 CDH12	1.45e-04	20	31	2	7806582
Pubmed	Impaired stria vascularis integrity upon loss of E-cadherin in basal cells.	CDH2 SLC2A1	1.45e-04	20	31	2	21925491
Pubmed	Micropattern differentiation of mouse pluripotent stem cells recapitulates embryo regionalized cell fate patterning.	GATA6 CDH2	1.45e-04	20	31	2	29412136
Pubmed	Four novel members of the connexin family of gap junction proteins. Molecular cloning, expression, and chromosome mapping.	LCK SLC2A1	1.45e-04	20	31	2	1370487
Pubmed	DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formation.	DAG1 CDH2	1.60e-04	21	31	2	33871356
Pubmed	NMRK2 Gene Is Upregulated in Dilated Cardiomyopathy and Required for Cardiac Function and NAD Levels during Aging.	SLC2A1 SLC2A4	1.60e-04	21	31	2	33805532
Pubmed	SOX9 is dispensable for the initiation of epigenetic remodeling and the activation of marker genes at the onset of chondrogenesis.	CDH2 TNC	1.60e-04	21	31	2	30021842
Pubmed	Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).	SLC2A1 SLC2A4	1.76e-04	22	31	2	20965718
Pubmed	Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium.	GATA6 IKZF1	1.76e-04	22	31	2	22863011
Cytoband	19p13.1	ADGRE2 ADGRE3	4.88e-04	48	31	2	19p13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr1p35	LCK RNF19B	3.88e-03	137	31	2	chr1p35
GeneFamily	CD molecules\|Adhesion G protein-coupled receptors, subfamily E	ADGRE2 ADGRE3	1.83e-05	5	25	2	915
GeneFamily	Solute carriers	SLC49A3 SLC2A13 SLC2A1 SLC2A4	1.97e-03	395	25	4	752
GeneFamily	L ribosomal proteins	RPL3 RPL3L	2.25e-03	51	25	2	729
ToppCell	COVID-19-kidney-Mito-rich_Int\|kidney / Disease (COVID-19 only), tissue and cell type	PCDH15 CYP1A1 HPSE2 EYS CDH12	2.87e-08	129	31	5	57b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 IKZF1 EYS CDH12	9.24e-08	163	31	5	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	COVID-19-kidney-Mito-rich_Int\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	1.53e-06	122	31	4	a4220adb4e6055a599bd9bbf65d460fc4e68b543
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	1.85e-06	128	31	4	91072ca56bce2c552a95edd67e17f43d8cc1de95
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	2.57e-06	139	31	4	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	COVID-19-kidney-Technical/muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	2.57e-06	139	31	4	13247bcb21c57c808657e0f543d6f134eeea7cc1
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	2.57e-06	139	31	4	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	3.13e-06	146	31	4	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	3.30e-06	148	31	4	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	3.30e-06	148	31	4	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	3.48e-06	150	31	4	0205318a870e091add66ee4305747dda9f51510d
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS CDH12	4.39e-06	159	31	4	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCDH15 HPSE2 GUCY2F CDH12	4.72e-06	162	31	4	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCDH15 IKZF1 EYS CDH12	5.85e-06	171	31	4	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	normal_Lung-Fibroblasts-Smooth_muscle_cells\|normal_Lung / Location, Cell class and cell subclass	HPSE2 CDH2 TNC SLC2A4	8.51e-06	188	31	4	fd70fb89570f014d1299c60fe017dc09f24e57c6
ToppCell	severe_COVID-19-CD4+_Tcm\|World / disease group, cell group and cell class (v2)	ACSL6 IKZF1 LCK RPL3	8.69e-06	189	31	4	8037fd4d799d95d9ca633a3efaf698539f696893
ToppCell	metastatic_Brain-T/NK_cells-CD4+_Th\|metastatic_Brain / Location, Cell class and cell subclass	ACSL6 IKZF1 LCK RPL3	8.69e-06	189	31	4	a2b00fbe7b7b15db3fce88a56cbac0ef2917332c
ToppCell	COVID-19-Heart-T_cell\|Heart / Disease (COVID-19 only), tissue and cell type	PCDH15 IKZF1 LCK SHANK2	8.87e-06	190	31	4	e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCell	severe_COVID-19-CD4+_Tcm\|severe_COVID-19 / disease group, cell group and cell class (v2)	ACSL6 IKZF1 LCK RPL3	9.05e-06	191	31	4	1ec86eaf90411ed200dbf51ae0cb5ed8060a7ec7
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNS1 SLC2A13 SHANK2 RTL1	9.43e-06	193	31	4	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNS1 SLC2A13 SHANK2 RTL1	9.43e-06	193	31	4	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	COVID-19_Severe-CD4+_Tcm\|COVID-19_Severe / disease group, cell group and cell class	ACSL6 IKZF1 LCK RPL3	9.43e-06	193	31	4	45fe14c10b71459047608c8931d83c9c533f97f9
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ACSL6 IKZF1 LCK RPL3	9.43e-06	193	31	4	792315f409a57fa6a8a88c850060b1e089e062ea
ToppCell	severe_COVID-19-CD4+_T_naive\|severe_COVID-19 / disease group, cell group and cell class (v2)	IKZF1 LCK RPL3 ABCE1	9.63e-06	194	31	4	4b86f3cc173ea779399d5b3598b45b25f60a4395
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ACSL6 IKZF1 LCK RPL3	1.00e-05	196	31	4	ecbc2baec21e85e6d8eac32d46f2c966fc35e223
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ACSL6 IKZF1 LCK RPL3	1.00e-05	196	31	4	b10810c6a2ad3d3b968bfef46a68a38e0ce31331
ToppCell	NS-critical-d_16-33-Lymphoid-Treg\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ACSL6 IKZF1 LCK RPL3	1.00e-05	196	31	4	ad2d17cbfa1af4142f9cec2ea1a37d11d4b4151a
ToppCell	normal_Pleural_Fluid-T/NK_cells-Naive_CD4+_T\|normal_Pleural_Fluid / Location, Cell class and cell subclass	ACSL6 IKZF1 LCK RPL3	1.02e-05	197	31	4	05cad1d1b16ca88d7100703dc2544bcf9f19319f
ToppCell	distal-Hematologic-CD4+_Naive_T\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ACSL6 IKZF1 LCK RPL3	1.04e-05	198	31	4	17ea354c1feea9905adfe06a1800bd7c871b2dd7
ToppCell	medial-Hematologic-CD4+_Naive_T-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ACSL6 IKZF1 LCK RPL3	1.06e-05	199	31	4	6a896a447388fd525cff207e17a5371c0f6b38cb
ToppCell	medial-2-Hematologic-CD4+_Naive_T\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ACSL6 IKZF1 LCK RPL3	1.06e-05	199	31	4	231a539899e2b76215da3e96a6755799f722e278
ToppCell	medial-Hematologic-CD4+_Naive_T\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ACSL6 IKZF1 LCK RPL3	1.06e-05	199	31	4	a54c35a646ae23bdd35c278ffb027408cf8dd553
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	LCK RTL1 RPL3L	2.09e-05	77	31	3	4a0a2f1a021790ff598a8655811eac1c367316b3
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	LCK RTL1 RPL3L	2.09e-05	77	31	3	459fe29a53b88af77a4ced7b11fa1d0a17fec8e5
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KCNS1 HPSE2 GUCY2F	3.12e-05	88	31	3	b4620e79ea80681305434707e87cb02a7c6a5e4f
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KCNS1 HPSE2 GUCY2F	3.12e-05	88	31	3	7992f8e621edf464bffcb70a6cc5f3b60c1d96f8
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KCNS1 HPSE2 GUCY2F	3.12e-05	88	31	3	b7b55f51af8ffa82813a4747580985a430da9ed1
ToppCell	Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	HPSE2 SLC49A3 SLC2A4	4.44e-05	99	31	3	8aab2a6989d342af387bd0823f79e7b326a12430
ToppCell	COVID-19-kidney-Epithelial_Doublet\|kidney / Disease (COVID-19 only), tissue and cell type	HPSE2 EYS CDH12	8.68e-05	124	31	3	d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9
ToppCell	COVID-19-kidney-Epithelial_Doublet\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCDH15 HPSE2 EYS	9.99e-05	130	31	3	1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b
ToppCell	facs-Marrow-B-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HPSE2 CDH2 SLC2A4	1.17e-04	137	31	3	4dcb15de821439011df1bb0bbd7682d674bd725d
ToppCell	facs-Marrow-B-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HPSE2 CDH2 SLC2A4	1.17e-04	137	31	3	c05ceeb7b483324604cb3f647d2da2b3786071b1
ToppCell	COVID-19-Fibroblasts-Mesothelial_FB\|COVID-19 / group, cell type (main and fine annotations)	GATA6 CDH2 CDH12	1.27e-04	141	31	3	7e6dcccb74e7ee90b69dc91b59491b84f3a713c9
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH15 HPSE2 GUCY2F	1.38e-04	145	31	3	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	CYP1A1 LCK MED12	1.44e-04	147	31	3	743767abdb3b5ecad870b617f515b037ce280818
ToppCell	LPS_only-Hematopoietic_Mast-Mast_cells-T-cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IKZF1 LCK CDH12	1.52e-04	150	31	3	ccb782fbcb3122266354a112a9a850506664f44d
ToppCell	LPS_only-Hematopoietic_Mast-Mast_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IKZF1 LCK CDH12	1.52e-04	150	31	3	7290e9a812b1b2f919e67ccde0acf52687ab138f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1A1 ADGRE2 TNC	1.52e-04	150	31	3	7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1A1 ADGRE2 TNC	1.52e-04	150	31	3	e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee
ToppCell	LPS_only-Hematopoietic_Mast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IKZF1 LCK CDH12	1.52e-04	150	31	3	2c5078a1f769ba8153dee756b53d28eb7b434a96
ToppCell	facs-MAT-Fat-3m-Lymphocytic-NK_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCK ADGRE2 GUCY2F	1.65e-04	154	31	3	391d40ef902773ffe832a50a14d35d31c56d3723
ToppCell	COVID-19-kidney-Mito-rich_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IKZF1 LCK OR52A1	1.65e-04	154	31	3	b437acc11e35fe05389e552d507f6f76e20cc102
ToppCell	severe_COVID-19-CD8+_T_naive\|severe_COVID-19 / disease group, cell group and cell class (v2)	ACSL6 IKZF1 LCK	1.71e-04	156	31	3	47aa46cdf5af9834f4b890ac6ce5e8d548ee98db
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EYS RPL3L TNC	1.74e-04	157	31	3	c779a53b2c67d566f5d417e753cd17196a6bfd1c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDH15 CDH2 TNC	1.78e-04	158	31	3	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	HPSE2 CDH2 TNC	1.84e-04	160	31	3	d783d29150033e9181c0e30870070268fed3fd85
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC49A3 SHANK2 RPL3L	1.88e-04	161	31	3	1e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KCNS1 EYS LCK	1.91e-04	162	31	3	19395bdb282b4a2d88cd33191af12c24a88c3d16
ToppCell	facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 RPL3L RNF19B	1.91e-04	162	31	3	3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704
ToppCell	facs-Lung-nan-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 RPL3L RNF19B	1.91e-04	162	31	3	8134f73eb76693f4f1845f643042fdc1e81c274c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PCDH15 EYS CDH12	2.09e-04	167	31	3	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PCDH15 IKZF1 LCK	2.09e-04	167	31	3	ded4d6cccd3660662f12cf5a512de31d26325f1b
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC49A3 SHANK2 SLC2A1	2.09e-04	167	31	3	3c06894fc6177f3c204094719904da42f08b9af8
ToppCell	droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRE2 RPL3L RNF19B	2.17e-04	169	31	3	c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d
ToppCell	IIF-Lymphocyte-T_NK-Treg\|IIF / Disease, Lineage and Cell Type	LCK RPL3 CDH12	2.17e-04	169	31	3	aac6ff89e0b3bc1f644e6cc6a696360659b254b5
ToppCell	Control-Lymphocyte-T_NK-MAIT\|Control / Disease, Lineage and Cell Type	HPSE2 LCK CDH2	2.17e-04	169	31	3	8c2aac193a9c500f01a99a2ee530839c851b6222
ToppCell	droplet-Lung-nan-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRE2 RPL3L RNF19B	2.17e-04	169	31	3	ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b
ToppCell	droplet-Liver-Npc\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK ADGRE2	2.20e-04	170	31	3	09c836840216905d545a25a4fc1bbd0699576c77
ToppCell	droplet-Liver-Npc-18m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK ADGRE2	2.24e-04	171	31	3	e9c42ce444d42cbb4f97e81393756531bfe61637
ToppCell	droplet-Lung-nan-21m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRE2 GUCY2F RPL3L	2.28e-04	172	31	3	51bea97564a33f0060c546c9be4bf8bf8f1660f6
ToppCell	droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRE2 GUCY2F RPL3L	2.28e-04	172	31	3	be4dd4ba8d7a651677c797c25fd75f14e627415a
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	HPSE2 CDH2 TNC	2.32e-04	173	31	3	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HPSE2 SLC49A3 TNC	2.36e-04	174	31	3	eb8012823b08729b462d1e5212f4873bb6b4eb1e
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HPSE2 SLC49A3 TNC	2.36e-04	174	31	3	32fdeeebeeeca657eac6329caad4c28ca54e4d1c
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IKZF1 LCK RPL3	2.40e-04	175	31	3	f7547eade69aa1d012db963adf59f36a309beae6
ToppCell	facs-GAT-Fat-3m-Lymphocytic\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK ADGRE2	2.44e-04	176	31	3	2e3f25a338842384517656d05776a52cbfc62b52
ToppCell	facs-GAT-Fat-3m-Lymphocytic-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK ADGRE2	2.44e-04	176	31	3	0823088bc6b19c7ad784d83c2ccdfae80611afab
ToppCell	Control-Lymphocyte-T_NK-CD8_TCM\|Control / Disease, Lineage and Cell Type	ACSL6 LCK RPL3	2.44e-04	176	31	3	1a7948eb86ee1da607db4d0576312b2859d94523
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_THEMIS_ELOF1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNS1 TNC CDH12	2.44e-04	176	31	3	78306517b1e52411a2ba72f141efea4d12c09f25
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCDH15 HPSE2 EYS	2.44e-04	176	31	3	014aa4a9aeae37309d7e05b20a06893a50f10bfe
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HPSE2 SHANK2 RTL1	2.48e-04	177	31	3	8abdf1d970b2f15e17e185f3e612dd5065c88757
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IKZF1 LCK RPL3	2.48e-04	177	31	3	0d6167c6a11c7dec0717ae7c8b4c45341585804f
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IKZF1 LCK RPL3	2.52e-04	178	31	3	a8d6aae3c35de6e7d1421cc48e58688adbdf16aa
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK RPL3	2.52e-04	178	31	3	ff80288fb54cdd25ce3e1c638b67d5db2a456e48
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDH2 TNC CDH12	2.52e-04	178	31	3	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IKZF1 EYS LCK	2.56e-04	179	31	3	dd3cf8fd10dc257d933a7f45860dc2e244c158b7
ToppCell	droplet-Mammary_Gland-nan-18m-Lymphocytic-T_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK RPL3	2.56e-04	179	31	3	48ee1c6d6402c7f5d6578f8de14da6f55aa952d6
ToppCell	metastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T\|metastatic_Lymph_Node / Location, Cell class and cell subclass	ACSL6 LCK RPL3	2.61e-04	180	31	3	16516dd9c78c27fc76f58d650de9851ffa0763e7
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IKZF1 EYS LCK	2.61e-04	180	31	3	ca7c316027e31559103b2cab1a2c0de993e42e95
ToppCell	droplet-Mammary_Gland-nan-18m-Lymphocytic-T_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK RPL3	2.61e-04	180	31	3	7bdc040461f350dd3136219341b39679fbca317e
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IKZF1 EYS LCK	2.61e-04	180	31	3	eb26ba86fba26899e54c448afc25382ddc853013
ToppCell	facs-SCAT-Fat-24m-Lymphocytic-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK ADGRE2	2.61e-04	180	31	3	86cdb1652f1736c38b501f07cf40ce99134cf597
ToppCell	18-Airway-RBC\|Airway / Age, Tissue, Lineage and Cell class	ACSL6 SLC2A1 SLC2A4	2.61e-04	180	31	3	35bf5f35cf346a5b27f5e819b77db34130d70db1
ToppCell	18-Airway-RBC-RBC\|Airway / Age, Tissue, Lineage and Cell class	ACSL6 SLC2A1 SLC2A4	2.61e-04	180	31	3	3b4b220a3c150426ae55239baff756f1a7f1e1d7
ToppCell	facs-SCAT-Fat-24m-Lymphocytic\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF1 LCK ADGRE2	2.61e-04	180	31	3	115ce9f048f933704a19759948dcc933245e63c4
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HPSE2 CDH2 TNC	2.65e-04	181	31	3	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IKZF1 LCK ADGRE2	2.65e-04	181	31	3	1110a0375189c034e6b02e6ebceb7084e4590114
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HPSE2 CDH2 TNC	2.65e-04	181	31	3	eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HPSE2 CDH2 TNC	2.65e-04	181	31	3	9c157de9d3403e092c907599f2a2c16db5b21131
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IKZF1 EYS LCK	2.69e-04	182	31	3	09d0793245d3d77ab5fc384c0b62637f736da50b
Drug	strontium chromate	ADGRE2 GUCY2F RPL3 RPL3L TNC	2.18e-07	99	31	5	CID000024599
Drug	alpha-pinene	CYP1A1 SAGE1 ADGRE2 ADGRE3	1.21e-06	59	31	4	CID000006654
Drug	hexaglycine	SLC2A1 SLC2A4	5.38e-06	3	31	2	CID000138069
Drug	Hexoses	SLC2A1 SLC2A4	5.38e-06	3	31	2	ctd:D006601
Drug	mucic acid	HPSE2 ADGRE2 MED12 ADGRE3	6.05e-06	88	31	4	CID000000607
Drug	chromium picolinate	SLC2A13 SLC2A1 SLC2A4	1.33e-05	34	31	3	CID000151932
Drug	rofecoxib	CDH2 TNC SLC2A1 SLC2A4	1.63e-05	113	31	4	ctd:C116926
Drug	YC-17	SLC2A1 SLC2A4	2.68e-05	6	31	2	CID005282032
Drug	dibenzacridine	DAG1 CYP1A1	2.68e-05	6	31	2	CID000009177
Drug	muconomycin A	RPL3 RPL3L	3.75e-05	7	31	2	CID000104830
Drug	heptanal	CYP1A1 ADGRE2	5.00e-05	8	31	2	ctd:C046204
Drug	7-hydroxyflavone	CYP1A1 SLC2A1	6.42e-05	9	31	2	CID005281894
Drug	NBDG	SLC2A1 SLC2A4	6.42e-05	9	31	2	CID000163790
Drug	myristicin	CYP1A1 SAGE1	8.02e-05	10	31	2	CID000004276
Drug	nd-8	RPL3 RPL3L	8.02e-05	10	31	2	CID000020806
Drug	caprylic aldehyde	CYP1A1 ADGRE2	8.02e-05	10	31	2	ctd:C031639
Drug	alpha-CaM	SHANK2 CDH2 TNC	8.19e-05	62	31	3	CID000196705
Drug	1,2-diglyceride	IKZF1 SLC2A13 SLC2A1 SLC2A4	9.02e-05	175	31	4	CID000192866
Drug	visnagin	SAGE1 TNC	9.79e-05	11	31	2	CID000006716
Drug	7-hydroxyflavone	CYP1A1 SLC2A1	9.79e-05	11	31	2	ctd:C429845
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; HL60; HT_HG-U133A	LCK SHANK2 RPL3L SLC2A4	1.10e-04	184	31	4	2168_UP
Drug	Hycanthone [3105-97-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CYP1A1 HPSE2 ADGRE3 RNF19B	1.10e-04	184	31	4	3229_UP
Drug	Acarbose	SLC2A1 SLC2A4	1.17e-04	12	31	2	ctd:D020909
Drug	L-364,373	RPL3 RPL3L	1.17e-04	12	31	2	CID000656755
Drug	IAPS-forskolin	SLC2A1 SLC2A4	1.17e-04	12	31	2	CID000163853
Drug	D 8731	SLC2A1 SLC2A4	1.17e-04	12	31	2	CID000132562
Drug	monomethylarsonic acid	CYP1A1 CDH2 SLC2A1	1.23e-04	71	31	3	ctd:C020300
Drug	isoliquiritigenin	CYP1A1 SLC2A1 SLC2A4	1.33e-04	73	31	3	ctd:C040920
Drug	Imidurea [39236-46-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A	KCNS1 HPSE2 SHANK2 ADGRE3	1.37e-04	195	31	4	3522_UP
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A	IKZF1 SHANK2 TNC OR52A1	1.37e-04	195	31	4	4105_UP
Drug	clozapine N-oxide	CYP1A1 SLC2A1	1.39e-04	13	31	2	CID000036727
Drug	PF-00875133-00 [351322-64-0]; Down 200; 10uM; PC3; HT_HG-U133A	CYP1A1 KCNS1 SHANK2 TNC	1.40e-04	196	31	4	5928_DN
Drug	Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A	KCNS1 SHANK2 CDH2 ADGRE3	1.42e-04	197	31	4	4160_UP
Drug	Methylatropine nitrate [52-88-0]; Up 200; 11uM; PC3; HT_HG-U133A	KCNS1 IKZF1 TNC RNF19B	1.42e-04	197	31	4	7253_UP
Drug	Propidium iodide [25535-16-4]; Up 200; 6uM; PC3; HT_HG-U133A	CYP1A1 KCNS1 ADGRE2 OR52A1	1.42e-04	197	31	4	5803_UP
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A	CYP1A1 KCNS1 IKZF1 TNC	1.45e-04	198	31	4	5390_UP
Drug	Troleandomycin [2751-09-9]; Up 200; 5uM; MCF7; HT_HG-U133A	KCNS1 IKZF1 CDH2 TNC	1.45e-04	198	31	4	1465_UP
Drug	Streptozotocin [18883-66-4]; Up 200; 15uM; MCF7; HT_HG-U133A	HPSE2 SHANK2 TNC OR52A1	1.48e-04	199	31	4	6098_UP
Drug	Ungerine nitrate; Up 200; 10.2uM; MCF7; HT_HG-U133A	CYP1A1 KCNS1 HPSE2 OR52A1	1.48e-04	199	31	4	6076_UP
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	KCNS1 IKZF1 CDH2 OR52A1	1.51e-04	200	31	4	6023_UP
Drug	ATB-BMPA	SLC2A1 SLC2A4	1.62e-04	14	31	2	CID000122117
Drug	15,16-dihydrotanshinone I	CYP1A1 SLC2A1	1.62e-04	14	31	2	ctd:C401932
Drug	ethoprop	SHANK2 ABCE1	1.62e-04	14	31	2	CID000003289
Drug	2,4-thiazolidinedione	CYP1A1 SLC2A4	1.86e-04	15	31	2	ctd:C089946
Drug	GSVs	SLC2A1 SLC2A4	1.86e-04	15	31	2	CID009549801
Drug	D-triiodothyronine	CYP1A1 SLC2A13 MED12 SLC2A1 SLC2A4	2.11e-04	409	31	5	CID000000861
Drug	4,6-O-ethylidene-D-glucose	SLC2A1 SLC2A4	2.13e-04	16	31	2	CID000114511
Drug	chondroitin sulfate	DAG1 ADGRE2 CDH2 TNC ADGRE3	2.21e-04	413	31	5	CID000024766
Drug	biochanin A	CYP1A1 LCK CDH2	2.24e-04	87	31	3	ctd:C004541
Drug	2-hexulofuranose	SLC2A13 SLC2A1 SLC2A4	2.32e-04	88	31	3	CID000000716
Drug	sulfenamido-sulfonamides	SLC2A1 SLC2A4	2.41e-04	17	31	2	CID000065823
Drug	tyrphostin AG17	LCK SLC2A1	2.41e-04	17	31	2	CID000126295
Drug	AC1L9SSV	RPL3 RPL3L	2.41e-04	17	31	2	CID000475367
Drug	L-dehydroascorbic acid	SLC2A13 SLC2A1 SLC2A4	2.48e-04	90	31	3	CID000000835
Drug	Cycloheximide	DAG1 CYP1A1 ACSL6 LCK SLC2A1	3.15e-04	446	31	5	ctd:D003513
Disease	pulmonary hypertension (biomarker_via_orthology)	GATA6 CYP1A1 TNC SLC2A4	1.30e-06	80	30	4	DOID:6432 (biomarker_via_orthology)
Disease	homostachydrine measurement	ACSL6 EYS	7.74e-05	13	30	2	EFO_0021164
Disease	pyruvate measurement	PCDH15 IKZF1 CDH2 CDH12	1.51e-04	268	30	4	EFO_0010117
Disease	Lung Injury	CYP1A1 TNC	2.07e-04	21	30	2	C0273115
Disease	Chronic Lung Injury	CYP1A1 TNC	2.07e-04	21	30	2	C2350344
Disease	Depressive Symptoms	CYP1A1 KCNS1	3.20e-04	26	30	2	C0086132
Disease	type 2 diabetes mellitus (is_implicated_in)	CYP1A1 SLC2A1 SLC2A4	6.92e-04	171	30	3	DOID:9352 (is_implicated_in)
Disease	response to xenobiotic stimulus	PCDH15 CDH2 CDH12	8.29e-04	182	30	3	GO_0009410

Protein segments in the cluster

Peptide	Gene	Start	Entry
LMFPVGYGVPAVTVA	ADGRE2	646	Q9UHX3
SVPLGVKVDMTPIYG	CYP1A1	481	P04798
IRYTTPVGSPGVVCM	EYS	2241	Q5T1H1
TIDEAYPSMPVGITG	MTIF2	406	P46199
TTGFVPMYVGEVSPT	SLC2A1	136	P11166
LTSGLVPMYVGEIAP	SLC2A4	151	P14672
TVPGQIRPTMTIPGY	DAG1	396	Q14118
IRPTMTIPGYVEPTA	DAG1	401	Q14118
ITVYMPSVLTLVGIP	OR52A1	6	Q9UKL2
TEIVTHGRIPYPGMT	LCK	431	P06239
RPTYPGVLPTTMTGV	MED12	1871	Q93074
TVSMTTVGYGDVVPV	KCNS1	416	Q96KK3
LPYVGPSVTPMTIVE	KIF9	156	Q9HAQ2
GGSEVVPVISPMYQL	IKZF1	336	Q13422
GRTLVIPPVTMGFYV	HPSE2	566	Q8WWQ2
IYGTMPPGIATVTVI	PCDH15	901	Q96QU1
PVYVPTTRVGSMLPG	GATA6	186	Q92908
GVPSAYGVVTMPFSV	ABCE1	291	P61221
GPVVAGVVGLTMPRY	GUCY2F	986	P51841
VATVPEMSPVGAYVL	CDH12	166	P55289
VPEGSKPGTYVMTVT	CDH2	276	P19022
VGLGIGIASMTVPVY	SLC2A13	181	Q96QE2
KNVMTIITGYPTPGS	RTL1	791	A6NKG5
GIAIPAMVIGIPVYV	RNF19B	366	Q6ZMZ0
TPPMVVVGIVGYVET	RPL3	81	P39023
TPPLVVVGVVGYVAT	RPL3L	81	Q92901
YERQGIAVMTPTVPG	SHANK2	816	Q9UPX8
IMFPVGYGVPAVTVA	ADGRE3	466	Q9BY15
SMVVVPLYDTLGPGA	ACSL6	171	Q9UKU0
DIPLMLGVYTIPAGV	SLC49A3	191	Q6UXD7
PVIIYLTATGIPGMN	SAGE1	321	Q9NXZ1
MEIPGLRAGTPYTVT	TNC	1311	P24821
RITYVPITGGTPSMV	TNC	1741	P24821